Oric Pharmaceuticals, Inc. (ORIC)
11.11
-0.22
(-1.94%)
USD |
NASDAQ |
Feb 20, 16:00
10.70
-0.41
(-3.69%)
After-Hours: 20:00
Oric Pharmaceuticals EPS Diluted (Quarterly) : -0.3293 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Krystal Biotech, Inc. | 1.699 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.59M |
| Total Expenses (Quarterly) | 32.59M |
| Enterprise Value | 819.58M |
| Earnings Yield | -15.58% |
| Normalized Earnings Yield | -15.58 |